Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Sanofi
51 Articles Available
0
3
Can't find what you're looking for? Try our
advanced search
.
COVID-19 Vaccine
Sanofi and GSK COVID-19 Vaccine Candidate Demonstrates Strong Immune Responses Across All Adult Age Groups in Phase 2 Trial
PR-M05-21-011
Vaccine Manufacturing
Sanofi to Help Manufacture Moderna's COVID-19 Vaccine
PR-M04-21-029
M&A
Sanofi Acquires Tidal Therapeutics and Adds an mRNA-Based Research Platform
PR-M04-21-012
Manufacturing
Sanofi to Invest in Vaccine Production Site in Singapore
PR-M04-21-011
COVID-19 Vaccine
Sanofi and GSK to Support COVAX with 200 Million Doses of COVID-19 Vaccine
PR-M10-20-18
COVID-19 Vaccine Funding
Sanofi and GSK Selected for Operation Warp Speed to Supply United States Government with 100 Million Doses of COVID-19 Vaccine
PR-M08-20-NI-05
Strategic Partnership
Kymera Therapeutics and Sanofi Enter into Strategic Partnership to Advance Novel Protein Degrader Therapies to Patients
PR-M07-20-NI-013
Collaboration
Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas
PR-M06-20-NI-027
FDA Approval
FDA Approves New Meningococcal Vaccination
PR-M04-20-NI-041
COVID-19 Clinical Trial
Sanofi and Regeneron Provide Update on U.S. Phase 2/3 Adaptive-Designed Trial in Hospitalized COVID-19 Patients
PR-M04-20-NI-040
COVID-19 Self-Testing
Sanofi and Luminostics to Join Forces on Developing COVID-19 Smartphone-based Self-Testing Solution
PR-M04-20-NI-030
Sanofi and GSK to Join Forces in COVID-19 Vaccine Collaboration
PR-M04-20-NI-020
Diabetes
Sanofi to Exit Diabetes and Cardiovascular Research
PAO-M12-19-NI-005
M&A
Sanofi to Acquire Synthorx to Bolster its Immuno-Oncology Pipeline for $2.5 Billion
PR-M12-19-NI-016
PR-M09-19-NI-032
Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement With Sanofi
PR-M09-19-NI-032
Marketing
Visual Marketing Strategy for Libtayo
PAO-M08-19-NI-005
Market Growth
Sanofi Delivered Solid Growth in Q2 2019
PR-M07-19-NI-077
Influenza
Sanofi Signs Strategic Deal for Exclusive US Over-the-Counter Rights to Tamiflu® in Flu Care
PR-M07-19-NI-061
Restructure
Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update
PR-M06-19-NI-032
Patent
Regeneron and Sanofi Strongly Disagree with Verdict Upholding Three of Five Amgen U.S. Patent Claims Relating to PCSK9 Antibodies
PR-M02-19-NI-059
Appointment
Sanofi CEO Olivier Brandicourt Becomes PhRMA Board Chairman
PR-M02-19-NI-007
Immuno-oncology
Regeneron and Sanofi Restructure Immuno-Oncology Collaboration for Discovery and Development Programs
PR-M01-19-NI-031
Immuno-oncology
Sanofi and Regeneron Immuno-oncology Collaboration Ending
PAO-M01-19-NI-012
New Facility
Sanofi to Consolidate Massachusetts Activities
PAO-M12-18-NI-017
«
0
3
»
.svg)
